Processing your payment...
Please do not close your browser.

Venous Leg Ulcer (VLU) Treatment Market - global growth, trends and forecast (2022 - 2027) By types, By application, By regions and By key players: Alliancebernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp(NASDAQ: IART)

09 Jun, 2022 | 108 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

The global Venous Leg Ulcer (VLU) Treatment Market will register a 16.71% cagr in terms of revenue, the global market size will reach us$ 169.50 million by 2027.



Venous Leg Ulcer (VLU) Treatment Market Overview



A venous leg ulcer is a long-term chronic sore on the inside of the leg, directly above the ankle. It can develop as a result of a small injury in which the skin has been injured by chronically high pressure in the veins. According to the NHS, the most frequent type of leg ulcer is a venous leg ulcer, which accounts for over 90% of all occurrences and affects almost 1 in 500 persons in the UK. The rise in the prevalence of venous leg ulcers and the use of compression therapy for the treatment of venous leg ulcers are the primary drivers of market expansion throughout the forecast period.



Rising knowledge regarding the availability of treatment options for venous leg ulcers, as well as innovations in treatment processes, are expected to drive the VLU treatment market growth during the forecast period.



This report contains data on sales and revenue for the past and predicted periods of time (2022 to 2027). Understanding the segments aids in determining the importance of various market growth variables. This Venous Leg Ulcer Treatment Market study assesses estimates of the CAGR value for a certain forecast period, market drivers, market restraints, and competitive strategies.



Who are the major players in the Venous Leg Ulcer (VLU) Treatment Market?



Top key players in the Venous Leg Ulcer (VLU) Treatment market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Venous Leg Ulcer (VLU) Treatment market is fragmented with a large number of small players operating worldwide. The companies referred to in the market research report include Alliancebernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp(NASDAQ: IART), Cardinal Health Inc (NYSE: CAH), 3M co (NYSE: MMM), Mölnlycke Health Care, Smith & Nephew plc., URGO Medical, Bauerfeind, PAUL HARTMANN AG, SIGVARIS and other.



Industry News;



Integra LifeSciences Announces Launch of Integra(R) Flowable Wound Matrix in Europe for Diabetic Foot and Leg Ulcers



Jan. 18, 2013-- announced that it has received European CE Mark Certification for its Integra Flowable Wound Matrix, an advanced device approved in the European Union for filling deep soft tissue or tunnelling wounds, including diabetic foot and leg ulcers.Integra LifeSciences Announces Launch Of Integra(R) Flowable Wound Matrix In Europe For Diabetic Foot And Leg Ulcers Integra LifeSciences Announces Launch Of Integra(R) Flowable Wound Matrix In Europe For Diabetic Foot And Leg Ulcers




What are the major applications, types and regions for Venous Leg Ulcer (VLU) Treatment Market?



Market is segmented based on the type, applications, companies and regions.



By type, Venous Leg Ulcer (VLU) Treatment Market has been segmented into 




  • Compression Therapy

  • Advanced Wound Dressings

  • Others



The end user’s industry application on Venous Leg Ulcer (VLU) Treatment Market is, 




  • Hospitals

  • Specialty Clinics

  • Homecare Settings

  • Others



Venous Leg Ulcer (VLU) Treatment Market regional analysis



Because of public initiatives connected to diabetes, North America is likely to have a dominating position in the worldwide vascular ulcers treatment market over the forecast period. The Centers for Disease Control and Prevention (CDC) added a new Social Determinants of Health (SDOH) module to the U.S. Diabetes Surveillance System on November 17, 2020, to aid in identifying underserved areas of the country and assessing the potential impact of health disparities on diabetes burden and risk factors. The SDOH module gives public health professionals and researchers a more in-depth look at the factors that may influence people's capacity to successfully manage and prevent type 2 diabetes across the United States.



North america






    • Us

    • Canada



  • Europe

    • Germany

    • France

    • Uk

    • Italy

    • Spain

    • Rest of europe



  • Asia-pacific

    • China

    • Japan

    • India

    • Australia

    • South korea

    • Rest of asia-pacific



  • Rest of the world

    • Middle east & africa

    • Latin america





The Venous Leg Ulcer (VLU) Treatment market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The global Venous Leg Ulcer (VLU) Treatment market report also conducted a pestel analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Venous Leg Ulcer (VLU) Treatment Market report scope?



























































Report attributes



Report details



Report title



Venous Leg Ulcer (VLU) Treatment Market - global growth, trends and forecast (2022 - 2027) by types, by application, by regions and by key players:  Alliancebernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp(NASDAQ: IART), Cardinal Health Inc (NYSE: CAH), 3M co (NYSE: MMM)



Forecast period 2022 to 2028 cagr



Cagr of 16.71% over the forecast period (2022-2027)



By type




  • Compression Therapy

  • Advanced Wound Dressings

  • Others



By application




  • Hospitals

  • Specialty Clinics

  • Homecare Settings

  • Others



By companies



Alliancebernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp(NASDAQ: IART), Cardinal Health Inc (NYSE: CAH), 3M co (NYSE: MMM), Mölnlycke Health Care, Smith & Nephew plc., URGO Medical, Bauerfeind, PAUL HARTMANN AG, SIGVARIS



Regions covered




  • North america

  • Europe

  • Asia-pacific

  • Rest of the world



Countries covered




  • Us

  • Canada

  • Germany

  • France

  • Uk

  • Italy

  • Spain

  • Rest of europe

  • China

  • Japan

  • India

  • Australia

  • South korea

  • Rest of asia-pacific

  • Middle east & africa

  • Latin america



Base year



2022



Historical year



2017 to 2021



Forecast year



2022 to 2027



Number of pages



108



Customization available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key takeaways from this evaluate Venous Leg Ulcer (VLU) Treatment report




  • Evaluate Venous Leg Ulcer (VLU) Treatment market potential through analyzing growth rates (cagr %), volume (units) and value ($m) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, swot and more.

  • Analyze the sales and distribution channels across key geographies to improve top-line revenues.

  • Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Venous Leg Ulcer (VLU) Treatment market entropy - m&a's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.



Frequently asked questions



What is the study period of this Market?



The Venous Leg Ulcer (VLU) Treatment market is studied from 2017 - 2027.



What is the growth rate of the Venous Leg Ulcer (VLU) Treatment Market?



The Venous Leg Ulcer (VLU) Treatment market is growing at a cagr of 16.71% over the next 5 years.



Who are the key players in the Venous Leg Ulcer (VLU) Treatment Market?



Alliance Bernstein Holding LP (NYSE: AB), Integra Lifesciences Holdings Corp (NASDAQ: IART), Cardinal Health Inc (NYSE: CAH), 3M co (NYSE: MMM), Mölnlycke Health Care, Smith & Nephew plc., URGO Medical, Bauerfeind, PAUL HARTMANN AG, SIGVARIS



What regions does this Venous Leg Ulcer (VLU) Treatment Market report covers?



North america (the united states, canada, and mexico)

europe (germany, france, uk, russia, and italy)

asia-pacific (china, japan, korea, india, and southeast asia)

south america (brazil, argentina, colombia, etc.)

The middle east and africa (saudi arabia, uae, egypt, nigeria, and south africa)



What are the significant types of Venous Leg Ulcer (VLU) Treatment Market?



Compression Therapy, Advanced Wound Dressings, Others



What are the major end-use applications of the Venous Leg Ulcer (VLU) Treatment Market?



Hospitals, Specialty Clinics, Homecare Settings, Others



All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.


  1. INTRODUCTION

    1. MARKET DEFINATION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMLINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL VENOUS LEG ULCER (VLU) TREATMENT MARKET BY TYPES

    3. VENOUS LEG ULCER (VLU) TREATMENT MARKET BY APPLICATIONS



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR VENOUS LEG ULCER (VLU) TREATMENT



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGUALTIONS

      2. HIGH COST ON MATERIALS



    3. OPPORTUNITIES

      1. VENOUS LEG ULCER (VLU) TREATMENT GROWTH

      2. APPLICATION OF VENOUS LEG ULCER (VLU) TREATMENT



    4. IMPACT OF COVID 19



  5. GLOBAL VENOUS LEG ULCER (VLU) TREATMENT MARKET, TYPES

    1. INTRODUCTION

    2. COMPRESSION THERAPY

    3. ADVANCED WOUND DRESSINGS

    4. OTHERS



  6. GLOBAL VENOUS LEG ULCER (VLU) TREATMENT MARKET, BY APPLICATION

    1. INTRODUCTION

    2. HOSPITALS

    3. SPECIALTY CLINICS

    4. HOMECARE SETTINGS

    5. OTHERS



  7. GLOBAL VENOUS LEG ULCER (VLU) TREATMENT MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. INTRODUCTION

      2. ALLIANCEBERNSTEIN HOLDING LP (NYSE: AB)

      3. INTEGRA LIFESCIENCES HOLDINGS CORP(NASDAQ: IART)

      4. CARDINAL HEALTH INC (NYSE: CAH)

      5. 3M CO (NYSE: MMM)

      6. MÖLNLYCKE HEALTH CARE

      7. SMITH & NEPHEW PLC.

      8. URGO MEDICAL

      9. BAUERFEIND

      10. PAUL HARTMANN AG

      11. SIGVARIS





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 3M
  • 3M
  • 9